CML Clinical Trial by Ascentage Pharma Group Inc

CML Clinical Trial by Ascentage Pharma Group Inc Information on the Ascentage Clinical Trial for CML Leukemia, Study of HQP1351 in Subjects With Refr

A multi-center, open-label, randomized, phase Ib study of an investigational drug to evaluate the pharmacokinetics (PK) of HQP1351 and to determine the recommended phase 2 dose (RP2D) of HQP1351 in subjects with CML chronic phase (CP), accelerated phase (AP) or blast phase (BP) or with Ph+ ALL, who have experienced resistance or intolerance to at least three tyrosine kinase inhibitors (TKIs).

Address

800 King Farm Boulevard , Suite 300
Rockville, MD
20850

Telephone

+18449273734

Website

Alerts

Be the first to know and let us send you an email when CML Clinical Trial by Ascentage Pharma Group Inc posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to CML Clinical Trial by Ascentage Pharma Group Inc:

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category